Published in Clin Cancer Res on April 25, 2017
Inference of population structure using multilocus genotype data. Genetics (2000) 147.76
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
Replicating genotype-phenotype associations. Nature (2007) 16.11
Fast model-based estimation of ancestry in unrelated individuals. Genome Res (2009) 15.63
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1993) 11.01
Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer (2012) 7.68
Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genet (2009) 6.61
African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet (2008) 6.06
Genomics for the world. Nature (2011) 3.68
Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA (2013) 3.65
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood (2002) 3.59
Accounting for ancestry: population substructure and genome-wide association studies. Hum Mol Genet (2008) 3.39
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer (2007) 3.27
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology (2000) 2.78
Joint analysis of functional genomic data and genome-wide association studies of 18 human traits. Am J Hum Genet (2014) 2.55
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Res (2011) 2.52
Chapter 11: Genome-wide association studies. PLoS Comput Biol (2012) 2.46
Statistical power and significance testing in large-scale genetic studies. Nat Rev Genet (2014) 2.25
Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel. Clin Cancer Res (2014) 2.25
Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol (2009) 2.20
Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. JAMA (2015) 2.20
Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J Clin Oncol (2012) 2.19
Genome-wide association studies in pharmacogenomics. Nat Rev Genet (2010) 2.14
Epidemiology of cancer-associated venous thrombosis. Blood (2013) 2.00
Human population structure and genetic association studies. Pharmacogenomics (2003) 2.00
The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia (2002) 1.96
Genetic variants associated with complex human diseases show wide variation across multiple populations. Public Health Genomics (2009) 1.93
Review and evaluation of methods correcting for population stratification with a focus on underlying statistical principles. Hum Hered (2008) 1.92
Personalized medicine in oncology: the future is now. Nat Rev Drug Discov (2010) 1.91
Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol (2015) 1.84
MaCH-admix: genotype imputation for admixed populations. Genet Epidemiol (2012) 1.77
The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics (1999) 1.76
Ancestry and disease in the age of genomic medicine. N Engl J Med (2010) 1.71
The genetic ancestry of African Americans, Latinos, and European Americans across the United States. Am J Hum Genet (2014) 1.61
HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer. J Clin Oncol (2011) 1.60
Estimating the mutation load in human genomes. Nat Rev Genet (2015) 1.57
Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. Blood (2015) 1.57
Cardiovascular Disease Mortality Among Breast Cancer Survivors. Epidemiology (2016) 1.52
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res (2012) 1.50
Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy. Clin Cancer Res (2009) 1.48
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Ann Oncol (2003) 1.38
Thrombotic events in patients with cancer receiving antiangiogenesis agents. J Clin Oncol (2009) 1.34
Sample size and statistical power calculation in genetic association studies. Genomics Inform (2012) 1.31
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nat Genet (2014) 1.27
Multiethnic genetic association studies improve power for locus discovery. PLoS One (2010) 1.23
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. Nat Genet (2015) 1.22
Genomics is failing on diversity. Nature (2016) 1.21
Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomarkers Prev (2015) 1.19
Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients. Pediatr Blood Cancer (2008) 1.18
Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia. Pediatr Blood Cancer (2010) 1.18
Genome-wide study of methotrexate clearance replicates SLCO1B1. Blood (2012) 1.17
Challenges in conducting genome-wide association studies in highly admixed multi-ethnic populations: the Generation R Study. Eur J Epidemiol (2015) 1.16
Fine-scale population structure and the era of next-generation sequencing. Hum Mol Genet (2010) 1.12
Impact of limited population diversity of genome-wide association studies. Genet Med (2010) 1.07
Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy. J Med Genet (2013) 1.03
Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. Cancer Sci (2013) 1.00
BRCA1/2 mutations and triple negative breast cancers. Breast Dis (2010) 0.99
Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans. PLoS One (2011) 0.99
Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199. Clin Cancer Res (2015) 0.98
Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol (2016) 0.97
Chemotherapy-induced peripheral neuropathy: Current status and progress. Gynecol Oncol (2015) 0.97
Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients. Cancer (2011) 0.95
Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer. Eur J Cancer (2011) 0.95
Bleeding and thrombosis in acute leukemia: what does the future of therapy look like? Thromb Res (2007) 0.94
Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE). Cancer (2011) 0.91
A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center. Cancer Med (2014) 0.91
Trans-ethnic study design approaches for fine-mapping. Eur J Hum Genet (2016) 0.89
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration. Pharmacogenomics J (2012) 0.87
Induction chemotherapy with docetaxel, cisplatin, fluorouracil and l-leucovorin for locally advanced head and neck cancers: a modified regimen for Japanese patients. Anticancer Drugs (2003) 0.87
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100. Br J Cancer (2014) 0.84
A feasibility study of paclitaxel and carboplatin therapy in Japanese patients with epithelial ovarian cancer. Oncol Rep (2003) 0.84
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss. Nat Genet (2015) 0.83
Genome-wide Association Study on Platinum-induced Hepatotoxicity in Non-Small Cell Lung Cancer Patients. Sci Rep (2015) 0.82
Pharmacogenomic variants have larger effect sizes than genetic variants associated with other dichotomous complex traits. Pharmacogenomics J (2015) 0.81
Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy. Pharmacogenomics J (2015) 0.81
Phase I and pharmacokinetic study of paclitaxel by 24-hour intravenous infusion. Jpn J Cancer Res (1994) 0.81
Effect of cisplatin on distortion product otoacoustic emissions in Japanese patients. Laryngoscope (2012) 0.81
Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia. Pharmacogenomics (2016) 0.80
Specific Safety Profile of Bevacizumab in Asian Patients With Advanced NSCLC: A Meta-Analysis. Medicine (Baltimore) (2015) 0.80
Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01. Pharmacogenomics J (2015) 0.80
New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients. Pharmacogenomics (2013) 0.79
Induction chemotherapy with docetaxel, cisplatin and S-1 followed by proton beam therapy concurrent with cisplatin in patients with T4b nasal and sinonasal malignancies. Jpn J Clin Oncol (2012) 0.79
Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia. J Clin Oncol (2016) 0.79
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer. J Clin Oncol (2016) 0.79
A coding variant in FTO confers susceptibility to thiopurine-induced leukopenia in East Asian patients with IBD. Gut (2016) 0.79
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy. Clin Cancer Res (2016) 0.78
Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment. Leuk Lymphoma (1999) 0.78
Using pharmacogene polymorphism panels to detect germline pharmacodynamic markers in oncology. Clin Cancer Res (2014) 0.78
GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis. Support Care Cancer (2014) 0.77
Genome-wide association study of epirubicin-induced leukopenia in Japanese patients. Pharmacogenet Genomics (2011) 0.77
High prevalence of cisplatin-induced ototoxicity in Cape Town, South Africa. S Afr Med J (2014) 0.76
Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity. Clin Cancer Res (2016) 0.76
Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance). J Natl Cancer Inst (2015) 0.76
Effect of Temporal Changes in Therapeutic Exposure on Self-reported Health Status in Childhood Cancer Survivors. Ann Intern Med (2016) 0.75
A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma. Clin Cancer Res (2016) 0.75
Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African-Americans. Oncotarget (2016) 0.75
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer. Clin Cancer Res (2017) 0.75